Wednesday, 17 July 2019

BioTech News

  • Pharma companies set eyes on China

    BioTech |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. The country was followed by Australia with 40 deals and India and South...Read more

  • 5 major policy developments of 2012

    BioTech |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

    The Year 2012 has seen crucial policy changes in the bioscience industry around the world. These changes that have taken place in 2012 hope to have an impact on the businesses of pharma, bi...Read more

  • Aus, NZ get automated culture systems from TAP

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

    Singapore: UK-based TAP Biosystems has appointed Australia's TrendBio, a company that supplies high quality life science research products, in order to provide scientists in Australia and N...Read more

  • Alnylam and Ascletis collaborate to develop RNAi liver cancer therapeutic

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jul, 2012

    Singapore: Alnylam Pharmaceuticals and Ascletis Pharmaceuticals have formed a strategic collaboration for the development of ALN-VSP, a first-in-class, systemically delivered RNAi therapeut...Read more

  • MEI Pharma gets new European patent for cancer

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 10 Oct, 2012

    Singapore: Australian firm Novogen's subsidiary MEI Pharma, an oncology company focused on the clinical development of novel therapies for cancer, has received a new patent from the Europea...Read more

  • Sandoz launches trial with Amgen biosimilar

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's Enbrel. With this, Novartis has consolidated its leading position in...Read more

  • Life Tech, SGC to pioneer epigenetic antibody technology

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jul, 2012

    Singapore: Life Technologies signed a collaborative partnership with the Structural Genomics Consortium (SGC) and scientists in antibody technology at the Universities of Chicago and Toront...Read more

  • Calgary Scientific expands into China

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2012

    Singapore: Calgary Scientific, a company known for creating transformative technology, is continuing to revolutionize global healthcare by expanding into Asia. Calgary Scientific hired Mr R...Read more

  • WuXi, OMT join hands to develop OmniRat antibodies

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: WuXi PharmaTech (Cayman), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the US, and Open Monoclonal Technol...Read more

  • Doctors now offer GI Dynamic's EndoBarrier Therapy to treat diabetes

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: GI Dynamics announced that doctors at St. Vincent's Clinic and Macquarie University Hospital (MUH) in Sydney now offer EndoBarrier Therapy, a revolutionary, non-surgical, non-ph...Read more

  • A*STAR Scientists Discover Potential Drug for Deadly Brain Cancer

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults - glioblastoma multiforme. The scientists found that by targeting this biomarker...Read more

  • Early Hep B treatment effective in clearing virus

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Scientists from A*STAR's Singapore Institute for Clinical Sciences (SICS), together with clinical collaborators from London, have discovered that children and young patients with...Read more

  • Indo-Aussie research to find ovarian cancer cure

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Scientists at Australia's Queensland University of Technology (QUT) are hot on the trail of a genetic pathway that regulates ovarian cancer stem cells. The university is collabor...Read more

  • Japan scientists pioneer new stem cell technology

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

    Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), succeeded in fabricating two types of cell matrix materials that mimic...Read more

  • joimax goes BRIC and beyond

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Right on time with the soon expected registrations of the joimax products in Brazil - one of the most emerging BRIC economies - the German-based company showed a very successful...Read more

  • NIH develops groundbreaking dengue vaccine

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jan, 2013

    Singapore: A dengue vaccine candidate developed by the National Institutes of Health (NIH) has shown to be safe and has generated a strong immune response. The early-stage clinical trial wa...Read more

  • Malvern acquires nanoparticle firm NanoSight

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: UK-based Malvern Instruments, a leading global provider of instrumentation and expertise for materials and biophysical characterization, has acquired nanoparticle characterizatio...Read more

  • Ambrx partners with WuXi to advance breast cancer treatement

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: In an effort to advance its breast cancer treatment, Ambrx has now partnered with WuXi PharmaTech and a Chinese drugmaker. As per the deal, Ambrx and Zhejiang Medicine will co-d...Read more



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls